Development of quinolone-resistant Campylobacter fetus bacteremia in human immunodeficiency virus - Infected patients

Journal of Infectious Diseases

Volumn 177, Issue 4, 1998, Pages 951-954

  Meier, Patricia A ^b   Dooley, David P ^a   Jorgensen, James H ^b   Sanders, Christine C ^b   Huang, Wai Mun ^b   Patterson, Jan E ^b  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

7 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 4 OXO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID; AMPICILLIN; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINAFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LOMEFLOXACIN; OFLOXACIN; OUTER MEMBRANE PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TEMAFLOXACIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; CAMPYLOBACTER FETUS; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031968879     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515248     Document Type: Article

References (15)

1. Schmidt U, Chmel H, Kaminski Z, Sen P. The clinical spectrum of Campylobacter fetus infections: report of five cases and review of the literature. Q J Med 1980;49:431-42.
2. Francioli P, Herzstein J, Grob JP, Valloton JJ, Mombelli G, Glauser MP. Campylobacter fetus subspecies fetus bacteremia. Arch Intern Med 1985;145:289-92.
3. Morrison VA, Lloyd BK, Chia JK, Tuazon CU. Cardiovascular and bacter-emic manifestations of Campylobacter fetus infection: case report and review. Rev Infect Dis 1990;12:387-92.
4. Carbone KM, Heinrich MC, Quinn TC. Thrombophlebitis and cellulitis due to Campylobacter fetus ssp. fetus. Medicine 1985;64:244-50.
5. Costel EE, Wheeler AP, Gregg CR. Campylobacter fetus ssp. fetus cholecystitis and relapsing bacteremia in a patient with acquired immunodeficiency syndrome. South Med J 1984;77:927-8.
6. Bernard E, Roger PM, Carles D, Bonaldi V, Fournier JP, Dellamonica P. Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virus. J Infect Dis 1989;159:143-4.
7. Rao GG, Karim QN, Maddocks A, Hillman RJ, Harris JR, Pinching AJ. Campylobacter fetus infections in two patients with AIDS (letter). J Infect 1990;20:170-2.
8. Fliegelman RM, Petrak RM, Goodman LJ, Segreti J, Trenholme GM, Kaplan RL. Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrob Agents Chemother 1985;27:429-30.
9. Goodman LJ, Fliegelman RM, Trenholme GM, Kaplan RL. Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens. Antimicrob Agents Chemother 1984;25: 504-6.
10. Goosens H, Coignau H, Vase L, Butzler JP. In vitro evaluation of antibiotic combinations against Campylobacter fetus. J Antimicrob Chemother 1989;24:195-201.
11. Morooka T, Shigeoka H. In vitro evaluation of antibiotics for treatment of meningitis caused by Campylobacter fetus subspecies fetus. Pediatr Infect Dis J 1989;8:653-4.
12. Segreti J, Gootz TD, Goodman LJ, et al. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis 1992; 165:667-70.
13. Redfield RR, Wright DC, Tramont EC. The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med 1986;314:131-2.
14. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. Villanova, PA: NCCLS, 1993.
15. Sanders CC, Sanders WE, Goering R, Werner V. Selection of multiple antibiotic resistance by quinolones, β-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother 1984;26:797-801.